BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3079320)

  • 21. The management of patients with advanced carcinoid tumors and islet cell carcinomas.
    Moertel CG; Johnson CM; McKusick MA; Martin JK; Nagorney DM; Kvols LK; Rubin J; Kunselman S
    Ann Intern Med; 1994 Feb; 120(4):302-9. PubMed ID: 8291824
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of disseminated midgut carcinoid tumours.
    Ahlman H; Wängberg B; Jansson S; Stenqvist O; Geterud K; Tylén U; Caidahl K; Scherstén T; Tisell LE
    Digestion; 1991; 49(2):78-96. PubMed ID: 1724766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Streptozocin plus fluorouracil versus doxorubicin therapy for metastatic carcinoid tumor.
    Engstrom PF; Lavin PT; Moertel CG; Folsch E; Douglass HO
    J Clin Oncol; 1984 Nov; 2(11):1255-9. PubMed ID: 6238136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcatheter arterial chemoembolization with DSM for primary hepatic malignant carcinoid.
    Hijioka S; Ikari T; Kamei A; Takano K; Asahara S; Fujita N; Shimizu M; Kuraoka K; Fijita R; Kanda H; Kato Y
    Hepatogastroenterology; 2007 Mar; 54(74):382-5. PubMed ID: 17523279
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Tumours of the midgut (jejunum, ileum and ascending colon, including carcinoid syndrome).
    de Herder WW
    Best Pract Res Clin Gastroenterol; 2005 Oct; 19(5):705-15. PubMed ID: 16253895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of the carcinoid tumor and the malignant carcinoid syndrome.
    Moertel CG
    J Clin Oncol; 1983 Nov; 1(11):727-40. PubMed ID: 6199469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic arterial embolisation in patients with metastatic carcinoid tumours.
    Odurny A; Birch SJ
    Clin Radiol; 1985 Nov; 36(6):597-602. PubMed ID: 2415290
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic considerations for the malignant carcinoid syndrome.
    Kvols LK
    Acta Oncol; 1989; 28(3):433-8. PubMed ID: 2663050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Octreotide treatment of carcinoid hypertensive crisis.
    Warner RR; Mani S; Profeta J; Grunstein E
    Mt Sinai J Med; 1994 Sep; 61(4):349-55. PubMed ID: 7969229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single dose of octreotide stabilize metastatic gastro-entero-pancreatic endocrine tumours.
    Angeletti S; Corleto VD; Schillaci O; Moretti A; Panzuto F; Annibale B; Delle Fave G
    Ital J Gastroenterol Hepatol; 1999; 31(1):23-7. PubMed ID: 10091100
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A case of liver metastases of rectal carcinoid successfully treated with hepatic arterial infusion of methotrexate and 5-fluorouracil].
    Takeuchi I; Ishida H; Suzuki T; Nakada H; Tada M; Idezuki Y
    Gan To Kagaku Ryoho; 1999 Oct; 26(12):1929-32. PubMed ID: 10560428
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical presentation and management of carcinoid tumors.
    Kulke MH
    Hematol Oncol Clin North Am; 2007 Jun; 21(3):433-55; vii-viii. PubMed ID: 17548033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A clinical overview of carcinoid tumors: perspectives for improvement in treatment using peptide analogs (review).
    Comaru-Schally AM; Schally AV
    Int J Oncol; 2005 Feb; 26(2):301-9. PubMed ID: 15645113
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Carcinoid tumors. Carcinoid syndrome. Clinicopathologic and therapeutic aspects].
    Torramadé Ribas J; Cienfuegos Suárez JA; Pardo Sánchez F; Hernández Lizoaín JL; Benito Fernández C; González Fernández J; De Villa Hoover V; Balen Rivera E
    Rev Esp Enferm Dig; 1991 Feb; 79(2):129-37. PubMed ID: 2059514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metastatic carcinoid tumors and the malignant carcinoid syndrome.
    Kvols LK; Reubi JC
    Acta Oncol; 1993; 32(2):197-201. PubMed ID: 8323761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dramatic response of a metastatic carcinoid tumour to a combination of interferon and octreotide.
    Joensuu H; Kätkä K; Kujari H
    Acta Endocrinol (Copenh); 1992 Feb; 126(2):184-5. PubMed ID: 1371898
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Continuous infusion of octreotide combined with perioperative octreotide bolus does not prevent intraoperative carcinoid crisis.
    Condron ME; Pommier SJ; Pommier RF
    Surgery; 2016 Jan; 159(1):358-65. PubMed ID: 26603846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon.
    Moertel CG; Rubin J; Kvols LK
    J Clin Oncol; 1989 Jul; 7(7):865-8. PubMed ID: 2738623
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastatic carcinoid tumors and the malignant carcinoid syndrome.
    Kvols LK
    Ann N Y Acad Sci; 1994 Sep; 733():464-70. PubMed ID: 7978896
    [No Abstract]   [Full Text] [Related]  

  • 40. Effective palliative treatment of metastatic carcinoid tumors with intra-arterial chemotherapy/chemoembolization combined with octreotide acetate.
    Hajarizadeh H; Ivancev K; Mueller CR; Fletcher WS; Woltering EA
    Am J Surg; 1992 May; 163(5):479-83. PubMed ID: 1374222
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.